A leading exchange expands its crypto lending service to the UK market

BTC-2.16%
ETH-2.8%
USDC0.02%
XRP-2.28%

Gate News message, April 20 — A leading exchange announced that UK users can now access its crypto lending service, allowing users to borrow USDC by using BTC, ETH, or cbETH as collateral. BTC holders can borrow up to $5 million in USDC. The service was launched for US users a year ago and is now provided through its subsidiary registered with the UK Financial Conduct Authority (FCA).

Morpho is a decentralized lending platform built on the Base layer. It provides back-end infrastructure, holds assets as collateral, and issues USDC loans. According to data from the Dune dashboard, the total borrowing activity facilitated through Morpho is approximately $2.3 billion—more than twice the $1 billion milestone celebrated in October 2025. Currently, UK borrowers can use only BTC and ETH as collateral, while US users can use XRP, DOGE, ADA, and LTC.

The expansion comes as the crypto lending market faces challenges. The $292 million KelpDAO exploit on April 18 triggered more than $1 billion in funds withdrawing from Morpho and led to an estimated $10 billion loss in Aave’s total value locked (TVL). Despite recent market volatility, Morpho remains the second-largest crypto lending platform with $6.6 billion in TVL, and active loans of more than $3.7 billion, behind only Aave.

Disclaimer: The information on this page may come from third parties and does not represent the views or opinions of Gate. The content displayed on this page is for reference only and does not constitute any financial, investment, or legal advice. Gate does not guarantee the accuracy or completeness of the information and shall not be liable for any losses arising from the use of this information. Virtual asset investments carry high risks and are subject to significant price volatility. You may lose all of your invested principal. Please fully understand the relevant risks and make prudent decisions based on your own financial situation and risk tolerance. For details, please refer to Disclaimer.
Comment
0/400
No comments